Yu J Cao

Years Active: 2021-2024
Publications (10 Years): 4

This page only lists publications with an associated author ORCID identifier.

Publications

Lijun Zhao, Shuhong Li, Xiaoyi Wei, Xuexiu Qi, Qiaoru Guo, Licai Shi, Ji-Shuai Zhang, Jun Li, Ze-Lin Liu, Zhi Guo, Hongyu Zhang, Jia Feng, Yuanyuan Shi, Suping Zhang, Yu J Cao
A novel loop-structure-based bispecific CAR that targets CD19 and CD22 with enhanced therapeutic efficacy against B-cell malignances. Protein & cell (2024)
Qiao-Ru Guo, Yu J Cao
Applications of genetic code expansion technology in eukaryotes. Protein & cell (2023)
Lijun Zhao, Shuhong Li, Xiaoyi Wei, Xuexiu Qi, Dong Liu, Lei Liu, Feiqiu Wen, Ji-Shuai Zhang, Feng Wang, Ze-Lin Liu, Yu J Cao
A novel CD19/CD22/CD3 trispecific antibody enhances therapeutic efficacy and overcomes immune escape against B-ALL. Blood 140 (16) (2022)
Yu J Cao, Xuechun Wang, Zhidong Wang, Lijun Zhao, Shuhong Li, Zhuxia Zhang, Xiaoyi Wei, Hwayoung Yun, Sei-Hyun Choi, Zhong Liu, Lili Zhao, Stephanie A Kazane
Switchable CAR-T Cells Outperformed Traditional Antibody-Redirected Therapeutics Targeting Breast Cancers. ACS synthetic biology 10 (5) (2021)

Yu J Cao.css-eqlu8i{font-size:small;padding-left:4px;}